Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 32 for your search:
Drug:  oblimersen sodium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: GENTA-GN304, NCI-G01-2046, UCLA-0301058, NCT00030641

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENTA-GM301, UCLA-0207109, NCT00016263

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENTA-GMY302, UF-G-29-2001, NCT00017602

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENTA-GL303, UCLA-0104008, NCT00024440

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02805, CALGB-10201, CDR367323, U10CA031946, NCT00085124

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AGENDA, GM307, NCT00518895

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-97096, GENTA-G3139-97/01, NCI-G97-1337, NCT00003103

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067529, SACI-IDD-98-32, UTHSC-IDD-98-32, NCI-T98-0094, T98-0094, NCT00004870

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10117, UCCRC-10017, NCI-T98-0091, T98-0091, NCT00005032

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENTA-GL208, MDA-ID-00337, NCT00021190

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271308, U01CA069853, P30CA054174, SACI-IDD-02-23, NCI-5793, 5793, NCT00055822

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01437, MC0285, MAYO-MC0285, NCI-5826, CDR0000304634, N01CM17104, 5826, NCT00062244

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GL217, NCT00078234

14.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02600, 12975A, N01CM62201, CDR0000371904, UCCRC-12975A, 6243, NCI-6243, NCT00086944

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENTA-GA210, UCCRC-10928, NCT00017589

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02819, CALGB 30103, U10CA031946, NCT00042978

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257565, PMH-PHL-011, NCI-5798, 5798, NCT00047229

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02790, CALGB 10107, U10CA031946, NCT00049192

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-00617, ID02-148, N01CM17003, N01CM62202, N01CM17107, N01CM62203, MDA-ID-02148, NCI-5808, 5808, NCT00054639

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02828, PHII-42, 5828, N01CM17101, CCC-PHII-42, CHNMC-PHII-42, NCI-5828, NCT00059813

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01446, 03-105, CDR0000354418, NCI-5907, MSKCC-03105, N01CM62207, N01CM62206, 5907, NCT00079131

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-30021, AVENTIS-AVE3139E/2501, NCT00085228

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000258058, MSGCC-210421, NCI-5824, 5824, NCT00049374

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01399, OSU-99H0257, OSU-9977, NCI-T99-0057, CDR0000067515, T99-0057, NCT00004862

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02387, 10992A, N01CM17102, CDR0000068667, UCCRC-10992A, NCI-5110, 5110, NCT00017251
1   
New Search